Interní Med. 2012; 14(4): 147-151

News in allergic disorders treatment

MUDr.Zuzana Humlová, Ph.D.

Ústav imunologie a mikrobiologie 1. LF UK a VFN, Praha

Increasing prevalence of allergic disorders is an important public health problem that needs a new therapeutical approaches and new

molecules for treatment. The knowledge about mechanisms of allergic inflammation is yearly broaden and offer new insights how this

process can be treated and symptoms can be mitigated. We have a large scale of antihistaminics including disperse form of tablets and

also new molecules from corticosteroids for treatment of allergic rhinitis and asthma. People suffering from asthma can be treated today

by powder or aerosol inhalators with combination of corticosteroids and long-acting beta-2-agonists. Patients suffering from severe

persisting allergic asthma can be treated by anti-IgE therapy. In causal therapy of allergy is possible to use tablet form of sublingual allergen

immunotherapy. Atopic dermatitis can be treated by topic immunomodulators – calcineurin inhibitors.

Keywords: antihistaminics, corticosteroides, allergen immunotherapy, anti-IgE therapy, calcineurin inhibitors

Published: April 23, 2012  Show citation